ESPAUR 2025: antibacterial resistance and the emergence of Candidozyma auris in England

The latest ESPAUR report (2024–2025) paints a sobering picture of AMR in England. While prescribing practices have improved in some areas, the resistant infections are increasing, and new threats like Candidozyma auris are emerging.

Continue reading

Candidozyma auris: an emerging threat

I’ve written this post in preparation for tomorrow’s Journal Club, which will be based on this NEJM review of Candidozyma auris (formerly Candida auris). You can register for Journal Club here (or watch the recording afterwards here).

Continue reading

C. auris – overview of an emerging threat

Useful Candida auris review just published in NEJM. Well worth a read. Here are some brief highlights and points for discussion.

Continue reading